Table 2.

Endorsers and Non-Endorsers: Assessments and Outcomes

	Endorsers (n=23)	Non-Endorsers (n=23)	p- value
YSR Scalesa
Internalizing	16 (69.6)b	3 (13)	≤0.001
Anxious/Depressed	10 (43.5)	2 (8.7)	0.017
Withdrawn/Depressed	7 (30.4)	1 (4.3)	0.047
Somatic Complaints	12 (52.2)	4 (17.4)	0.029
Externalizing	11 (47.8)	0 (0)	≤0.001
Aggressive Behaviors	11 (48)	0 (0)	0.000
Rule-Breaking Behaviors	2 (9)	0 (0)	0.489
Other Behaviors	-	-	-
Social Problems	8 (34.8)	1 (4.3)	0.022
Thought Problems	9 (39.1)	5 (21.7)	0.337
Attention Problems	3 (13.0)	0 (0)	0.233
Impulsivity
Acting Without Thinking	7.13 ± 2.8c	3.8 ± 2.8	≤0.001
Sensation Seeking	11.0 ± 3.5	7.5 ± 2.9	≤0.001
Total Risk Taking	3.0 ± 2.6	1.1 ± 1.5	0.05
Neurocognitive Function: Standard Scores
Working Memory
Corsi Block Tapping	97.2 ± 14.8	97.5 ± 13.4	0.96
Digit Span (WISC-IV)	101.2 ± 18.3	95.5 ± 15.5	0.30
Letter Two Back	100.2 ± 16.3	100.6 ± 16.5	0.95
Spatial Working Memory	97.5 ± 14.2	99.7 ± 16.7	0.63
Cognitive Control
Counting Stroop	105.0 ± 19.4	101.1 ± 15.0	0.46
Erikson Flanker	103.3 ± 12.9	102.2 ± 19.1	0.83
Reward Processing
Reversal Learning	99.0 ± 15.8	99.7 ± 16.7	0.89
Balloon Analogue Risk Task	91.8 ± 12.3	101.8 ± 13.7	0.013
Other Participant and Family Variables
Participant Report
Parental Involvement	2.5 ± 0.5	2.6 ± 0.4	0.41
Parent Report
Medical Issues	3 (13.0)	5 (21.7)	0.70
Behavioral/Emotional Issues	1 (4.3)	2 (8.7)	1.0
Stimulant Medication	1 (4.3)	5 (21.7)	0.19

^aBorderline/Clinical Range⁶

^bn (%)

^cMean ± SD